← Open Payments lookup

SAEID NEKOUEIAN: Open Payments

NPI 1356955462 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,156 in 37 payments from 8 companies in 2025. Trend: 2023 $1,840 · 2024 $2,306 · 2025 $2,156

Food & beverage: $2,156
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$523
E.R. Squibb & Sons, L.L.C.11$448
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$333
ABBVIE INC.5$289
Neurocrine BioSciences, Inc.5$202
Axsome Therapeutics, Inc.1$125
Otsuka America Pharmaceutical, Inc.1$120
Vanda Pharmaceuticals Inc.1$115

Products named: UZEDY, COBENFY, CAPLYTA, VRAYLAR, INGREZZA, Auvelity, ABILIFY ASIMTUFII, FANAPT.

Industry payments across TX — which companies pay providers there.